scholarly journals Attitudes Towards Cervical Cancer Screening

2006 ◽  
Vol 4 (2) ◽  
pp. 13-24 ◽  
Author(s):  
Myriam Leyva ◽  
Theresa Byrd ◽  
Patrick Tarwater
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Pap Smear ◽  
Screening Program ◽  
Pap Test ◽  
Mexican Women ◽  
Cancer Screening Program ◽  
Cervical Cancer Screening Program ◽  
Smear Testing

Pap smear testing continues to be the single most effective tool in reducing deaths due to cervical cancer (Watkins, Gabali, Winkleby, Gaona & Lebaron, 2002). Despite the creation of a national cervical cancer screening program, more than 4,000 women die every year in Mexico from this disease. This study explored the knowledge, attitudes, and behaviors of Mexican women regarding cervical cancer screening, and identified beliefs and barriers that may influence cervical health. All analyses compared women who had ever had a Pap test in their lives (“ever”) with women who had never had a Pap test (“never”). In bivariate analyses, the following variables were significantly associated (p

PP62 Cost-Effectiveness Of Cervical Cancer Screening In Estonia

2019 ◽  
Vol 35 (S1) ◽  
pp. 49-49
Author(s):  
Triin Võrno ◽  
Kaja-Triin Laisaar ◽  
Terje Raud ◽  
Kai Jõers ◽  
Doris Meigas-Tohver ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Screening Program ◽  
Pap Test ◽  
Cancer Screening Program ◽  
Hpv Test ◽  
Cervical Cancer Screening Program ◽  
The Cost

IntroductionIn Estonia, organized cervical cancer screening program is targeted at women aged 30–55(59) years and Pap-tests are taken every five years. Since cervical cancer is associated with human papillomavirus (HPV), a number of countries have introduced the HPV-test as the primary method of screening. The objective of this study was to evaluate the cost-effectiveness of organized cervical cancer screening program in Estonia by comparing HPV- and Pap-test based strategies.MethodsFor the cost-effectiveness analysis, a Markov cohort model was developed. The model was used to estimate costs and quality-adjusted life-years (QALYs) of eight screening strategies, varying the primary screening test and triage scenarios, upper age limit of screening, and testing interval. Incremental cost-effectiveness ratios (ICERs) were calculated in comparison to current screening practice as well as to the next best option. Sensitivity analysis was performed by varying one or more similar parameter(s) at a time, while holding others at their base case value. The analysis was performed from the healthcare payer perspective adopting a five percent annual discount rate for both costs and utilities.ResultsIn the base-case scenario, ICER for HPV-test based strategies in comparison to the current screening practice was estimated at EUR 8,596–9,786 per QALY. For alternative Pap-test based strategies ICER was estimated at EUR 2,332–2,425 per QALY. In comparison to the next best option, HPV-test based strategies were dominated by Pap-test based strategies. At the cost-effectiveness threshold of EUR 10,000 per QALY Pap-testing every three years would be the cost-effective strategy for women participating in the screening program from age 30 to 63 (ICER being EUR 3,112 per QALY).ConclusionsDecreasing Pap-test based screening interval or changing to HPV-test based screening can both improve the effectiveness of cervical cancer screening program in Estonia, but based on the current cost-effectiveness study Pap-test based screening every three years should be preferred.

scholarly journals Cervical Cancer Screening in Nepal

2013 ◽  
Vol 12 (1) ◽  
pp. 18-20 ◽  
Author(s):  
M Joshi ◽  
SR Mishra
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Pap Smear ◽  
Screening Program ◽  
Hpv Infection ◽  
Cancer Screening Program ◽  
Special Programs ◽  
Cervical Cancer Screening Program ◽  
Cervical Cells

Cervical cancer screening is a process using the Pap smear to identify precancerous and potentially precancerous changes in cervical cells and tissue. Cervical cancer acts as the biggest killer and most preventable cancer in Nepalese women. This paper tries to give a brief overview of cervical cancer screening program in Nepal. Various published and unpublished literatures were obtained and reviewed from international journals, local newspapers and books. All literatures were systematically reviewed and analyzed. Human papilloma virus (HPV) infection is chiefly the reason for cervical cancer. In majority cases, early exposure to sexual intercourse, multiple sex partners and addiction are considered as risk factor. In Developing country like Nepal, screening for cervical cancers is not easily available to people at risk. A vaccine is available which reduces the risk of HPV. The vaccine will be effective if received before the onset of sexual activities 9-13 years. Cervical cancer screening program has many difficulties in terms of limited medical services, difficult geographical terrain creating difficulties in delivering health services. Special programs needs to be designed and delivered to population focusing on reducing burden of cervical cancer. DOI: http://dx.doi.org/10.3126/hprospect.v12i1.8723 Health Prospect: Journal of Public Health Vol.12(1) 2013: 18-20

Individual and Community Effectiveness of a Cervical Cancer Screening Program for Semi-Urban Mexican Women

2013 ◽  
Vol 39 (3) ◽  
pp. 423-431 ◽  
Author(s):  
Adriana A. Figueroa-Muñoz Ledo ◽  
Margarita Márquez-Serrano ◽  
Alvaro J. Idrovo ◽  
Betania Allen-Leigh
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Screening Program ◽  
Mexican Women ◽  
Cancer Screening Program ◽  
Cervical Cancer Screening Program

scholarly journals Cervical cancer screening coverage in a high-incidence region

2015 ◽  
Vol 49 (0) ◽  
Author(s):  
Cibelli Navarro ◽  
Allex Jardim da Fonseca ◽  
Alexander Sibajev ◽  
Camila Iasmim de Andrade Souza ◽  
Daniela Souza Araújo ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Low Income ◽  
Pap Smear ◽  
Screening Program ◽  
Cluster Sampling ◽  
Cancer Screening Program ◽  
High Incidence ◽  
Cervical Cancer Screening Program

OBJECTIVE To analyze the coverage of a cervical cancer screening program in a city with a high incidence of the disease in addition to the factors associated with non-adherence to the current preventive program.METHODS A cross-sectional study based on household surveys was conducted. The sample was composed of women between 25 and 59 years of age of the city of Boa Vista, RR, Northern Brazil who were covered by the cervical cancer screening program. The cluster sampling method was used. The dependent variable was participation in a women’s health program, defined as undergoing at least one Pap smear in the 36 months prior to the interview; the explanatory variables were extracted from individual data. A generalized linear model was used.RESULTS 603 women were analyzed, with an mean age of 38.2 years (SD = 10.2). Five hundred and seventeen women underwent the screening test, and the prevalence of adherence in the last three years was up to 85.7% (95%CI 82.5;88.5). A high per capita household income and recent medical consultation were associated with the lower rate of not being tested in multivariate analysis. Disease ignorance, causes, and prevention methods were correlated with chances of non-adherence to the screening system; 20.0% of the women were reported to have undergone opportunistic and non-routine screening.CONCLUSIONS The informed level of coverage is high, exceeding the level recommended for the control of cervical cancer. The preventive program appears to be opportunistic in nature, particularly for the most vulnerable women (with low income and little information on the disease). Studies on the diagnostic quality of cervicovaginal cytology and therapeutic schedules for positive cases are necessary for understanding the barriers to the control of cervical cancer.

scholarly journals Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon

2021 ◽  
pp. ijgc-2021-002555
Author(s):  
Jessica Sormani ◽  
Alida Moukam Datchoua ◽  
Patrick Petignat ◽  
Bruno Kenfack ◽  
Nicole C Schmidt
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Screening Program ◽  
Cancer Screening Program ◽  
Cervical Cancer Screening Program
Sign in / Sign up

Export Citation Format

Share Document